Cargando…
Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors
Carbonic anhydrase II (CAII) is a zinc-containing metalloenzyme whose aberrant activity is associated with various diseases such as glaucoma, osteoporosis, and different types of tumors; therefore, the development of CAII inhibitors, which can represent promising therapeutic agents for the treatment...
Autores principales: | Poli, Giulio, Jha, Vibhu, Martinelli, Adriano, Supuran, Claudiu T., Tuccinardi, Tiziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073570/ https://www.ncbi.nlm.nih.gov/pubmed/29937490 http://dx.doi.org/10.3390/ijms19071851 |
Ejemplares similares
-
Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors
por: Poli, Giulio, et al.
Publicado: (2019) -
Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII
por: Buran, Kerem, et al.
Publicado: (2019) -
Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?
por: Supuran, Claudiu T.
Publicado: (2018) -
Carbonic Anhydrase Inhibitors. Part 46(1) Inhibition of Carbonic Anhydrase Isozymes I, II and IV With Trifluoromethylsulfonamide Derivatives and Their Zinc(II) and Copper(II) Complexes
por: Mincione, Giovanna, et al.
Publicado: (1997) -
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases?
por: Carradori, Simone, et al.
Publicado: (2022)